Downgrades Archives - Page 98 of 277

1 minute read

B of A Securities Downgrades Cyteir Therapeutics to Neutral, Lowers Price Target to $2

January 30, 8:17 AM

B of A Securities analyst Tazeen Ahmad downgrades Cyteir Therapeutics (NASDAQ:CYT) from Buy to Neutral and lowers the price target from $4 to $2.

CYT

1 minute read

Baird Downgrades Boot Barn Holdings to Neutral, Announces $86 Price Target

By Benzinga Newsdesk

January 30, 8:11 AM

Baird analyst Jonathan Komp downgrades Boot Barn Holdings (NYSE:BOOT) from Outperform to Neutral and announces $86 price target.

BOOT

1 minute read

Berenberg Downgrades General Motors to Hold, Lowers Price Target to $41

By Benzinga Newsdesk

January 30, 6:25 AM

Berenberg analyst Adrian Yanoshik downgrades General Motors (NYSE:GM) from Buy to Hold and lowers the price target from $45 to $41.

1 minute read

Credit Suisse Downgrades Saia to Neutral, Raises Price Target to $288

By Benzinga Newsdesk

January 30, 6:20 AM

Credit Suisse analyst Ariel Rosa downgrades Saia (NASDAQ:SAIA) from Outperform to Neutral and raises the price target from $269 to $288.

SAIA

1 minute read

Keybanc Downgrades Lulus Fashion Lounge to Sector Weight

By Benzinga Newsdesk

January 30, 5:36 AM

Keybanc analyst Noah Zatzkin downgrades Lulus Fashion Lounge (NASDAQ:LVLU) from Overweight to Sector Weight.

LVLU

2 minute read

Hess Corp. Gets Downgraded Despite Strong Performance: Here’s What Analysts Say

By AJ Fabino

January 27, 3:55 PM

Oil and gas producer Hess Corp. (NYSE: HES) has been a multi-year winner, delivering investors more than 228% returns in the last five years, against the S&P 500 (ARCA: SPY), which has delivered 47.56% in that same time frame.

COP

1 minute read

Wolfe Research Downgrades Northrop Grumman to Peer Perform

By Benzinga Newsdesk

January 27, 9:11 AM

Wolfe Research analyst Myles Walton downgrades Northrop Grumman (NYSE:NOC) from Outperform to Peer Perform.

NOC

1 minute read

Credit Suisse Downgrades Aveanna Healthcare Hldgs to Underperform, Lowers Price Target to $1

By Benzinga Newsdesk

January 27, 8:13 AM

Credit Suisse analyst A.J. Rice downgrades Aveanna Healthcare Hldgs (NASDAQ:AVAH) from Neutral to Underperform and lowers the price target from $2 to $1.

AVAH